Dihydrotachysterol and 5,6-trans-cholecalciferol are biologically active analogues of cholecalciferol (vitamin D) with a similarity in steric structure to 1,25-dihydroxycholecalciferol, the active form of the vitamin. The question arises as to the nature of the active form of these analogues. High specific radioactivity 14C-and 3H-labelled forms of dihydrotachysterol and 5,6-trans-cholecalciferol and its 25-hydroxy derivative were synthesized and their metabolism was studied in chicks and rats. All these steroids were very rapidly metabolized compared with cholecalciferol; 20% of the dihydrotachysterol dose was excreted in bile in the first 24h, about 50 % as a carboxylic acid derivative. Although polarmetabolites were detected in tissues, no 1-hydroxyformwas observed. Larger proportions of the parent steroid and its 25-hydroxy metabolite weredetected in tissuescompared withcholecalciferol, but no single metabolite was detected at the intracellular site of action of cholecalciferol. It is suggested that analogues of cholecalciferol will be biologically active if they possess a hydroxyl group in the same steric position as that at C-1 of cholecalciferol, with the greatest activity shown by those that also have a C-25 hydroxyl group. The implication of these findings for the chemical features necessary for binding to receptor proteins are briefly discussed.
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After the chemical characterization and synthesis of cholecalciferol there has been a continuing search for biologically and clinically valuable analogues of this vitamin. Side-chain variations in this molecule are not only found in nature but are chemically easier to effect than are modifications of the steroid nucleus, and thus their biological activity has been studied in some detail. In animals but not in birds cholecalciferol and ergocalciferol have similar antirachitic activity but any further change in the ergocalciferol side chain, e.g. substituting an ethyl group for a methyl group at C-24, decreases the activity considerably. In addition antirachitic activity is absent from those compounds containing a hydroxyl group in the side chain other than at C-25 or those in which the side chain has been shortened by one or more carbon atoms (see review by Norman, 1968; Bontekoe et al., 1970) . Studies of the metabolism of radioactively labelled cholecalciferol have led to the finding that the compound has to be hydroxylated at C-1 and C-25 to give 1,25-dihydroxycholecalciferol (I) before it is effective in its target tissues (Fraser & Kodicek, 1970; Lawson et al., 1971a; Gray et al., 1971; Holick et al., 1971; Norman et al., 1971) . Presumably therefore the requirement for an intact and unchanged side * Present address: Tenovus Institute for Cancer Research, The Heath, Cardiff CF4 4XX, U.K.
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chain is not only to maintain the C-25 hydroxyl group in the correct steric position but also to allow its interaction with receptors unhindered by the presence of other substituents.
Other analogues of cholecalciferol have been produced by the isomerization of the A ring or by reduction of one or more of the three double bonds. Of these substances the hypercalcaemic activity of dihydrotachysterol makes it not only of biological interest but also of clinical value. The hypercalcaemic activity of dihydrotachysterol3 (II, R = H) in chicks is about 5% of that of cholecalciferol (Hibberd & Norman, 1969) , whereas its antirachitic activity is much less than 1 % (Stohl & Farber, 1941 1, 1,25-Dihydroxycholecalciferol; II, R = H and R = OH, dihydrotachysterol3 and 25-hydroxydihydrotachysterol3 respectively; III, R = H and R = OH, 5,6-trans-cholecalciferol and 25-hydroxy-5,6-trans-cholecalciferol respectively; IV, R = H and R = OH, dihydrotachysterol2 and 25-hydroxydihydrotachysterol2 respectively; V, R = H and R = OH, 5,6-strans-ergocalciferol and 25-hydroxy-5,6-trans-ergocalciferol respectively; VI, dihydrocholecalciferol I; VII, dihydrocholecalciferol IV.
hydroxyl group occupying this same position (Fig. 1) . Although comparisons have been made of the relative potency of dihydrotachysterol and cholecalciferol (de Man & Roborgh, 1958; Bosmann & Chen, 1966; Hibberd & Norman, 1969) few similar studies have been carried out with 5,6-trans-cholecalciferol (Holick et al., 1972 ). It appears, though, that in both cases the relative potency is low, with the actual value depending on the particular metabolic effect of cholecalciferol being measured, and on the species involved.
Some studies of the metabolism of dihydrotachysterol in rats have been described (Hallick & DeLuca, 1972) and it has been shown that the biological activities of 5,6-trans-cholecalciferol are retained in anephric rats (Holick et al., 1972) . In the present paper we describe the synthesis of highly radioactive forms of these compounds and the metabolism of both substances in chicks and rats. Interest in these analogues stems from the advantages of establishing the structural features of the 1,25-dihydroxycholecalciferol essential for activity. Such information is necessary not only to have a full understanding of the interaction of this steroid with its receptors but also to aid the discovery of compounds that might inhibit thebiological action of1 ,25-dihydroxycholecalciferol. (c) Gas-liquid chromatography. This was performed with a Pye 104 instrument with a flame-ionization detector, on 1.54m (5ft) glass column packed with 3 % OV-1 on 80-100 mesh Diatomite CQ. The column temperature was 2200 or 240°C and the flow rate ofthe argon carrier was 50ml/min. Retention times were measured relative to So-cholestane (1.00).
(d) Chromatography on Sephadex LH-20. Some of the fractions obtained from the other chromatographic procedures were further fractionated on a column (60cmx 1.5cm) of Sephadex LH-20 (Pharmacia, Uppsala, Sweden), eluted with dichloromethane.
Animals
Rhode Island RedxLight Sussex chicks were obtained from the National Institute for Research in Dairying (Shinfield, Reading, U.K.). They were fed on the diets and supplements as described by Lawson et al. (1969) and were used after 4 weeks, when they were vitamin D-deficient. Piebald weanling rats were raised on the diet of Numeroff et al. (1955) . Unless otherwise stated the dosing material was administered intracardially in propylene glycol 16h before the animals were killed. In all experiments the animals were starved overnight before being killed.
Lipid extraction
Suspensions of tissues and tissue fractions were extracted with chloroform-methanol by the method of Bligh & Dyer (1959) , and the lipids in the chloroform phase were taken for chromatography or radioactivity measurements. Reduction oftachysterol by lithium in liquid NH3 NH3 gas was dried over KOH pellets and condensed in a flask cooled in a bath containing acetone and solid CO2. When 50ml of NH3 had been condensed, dry diethyl ether (25ml) was added, followed by a trace of lithium which gave a lasting blue coloration and confirmed the absence of water. Lithium wire (50mg) was added and the solution was stirred for 10min. After the addition of tachysterol3 (50mg) in dry diethyl ether (lOml), stirring was continued for a further 5min, and then the mixture was decomposed by the addition of solid NH4Cl followed by the cautious addition of water. The mixture was allowed to warm to room temperature, and the ether phase was washed several times with water. After brief drying over anhydrous Na2SO4 the ether extract was evaporated to dryness. The crude product had 1max. 250nm and gave two unresolved peaks on g.l.c. with retention times at 220°C relative to the 5a-cholestane marker (1.00) of 1.71 and 1.91 (Fig. 2a) This compound was prepared by the reduction method described above from [1,2-3H2]tachysterol3 (74mg), obtained as a by-product in the preparation of [1,2-3H2]cholecalciferol (Lawson et al., 1971b Reduction of [1-3H]tachysterol2 (Pelc & Kodicek, 1971 ) with lithium in liquid NH3, and work-up by the procedures detailed above, gave [1-3H]dihydrotachysterol2 (0.87mg of specific radioactivity 168mCi/ mmol). Reduction of [4-14C]tachysterol2 (Pelc & Kodicek, 1972) gave, after purification, [4-'4C]dihydrotachysterol2 (0.20mg) of specific radioactivity 28.6mCi/ mmol.
25-Hydroxydihydrotachysterol3
The starting material for this preparation was 25-oxo-26-nortachysterol3 (400mg), obtained as a by-product from the preparation of 25-oxo-26-norcholecalciferol (Bell & Scott, 1973) . The starting material, in dry diethyl ether (50ml), was refluxed for 30min with the Grignard reagent prepared from magnesium (0.49g) and methyl iodide (2.98g) in dry diethyl ether (50ml). The complex was decomposed by the addition of saturated NH4C1, and the ether layer was separated, washed with water, briefly dried over anhydrous Na2SO4, and concentrated under reduced pressure.
The crude product showed Amax. 279nm, and gave a single spot on t.l.c. of considerably higher polarity than the starting material. The crude 25-hydroxytachysterol3 was reduced without further purification by using lithium (200mg) in liquid NH3 (50ml). After the usual extraction the product was purified by preparative t.l.c. cholecalciferol (III, R = OH) was 2.70mg, and the specific radioactivity was 62mCi/mmol. The compound had 'max. 274nm, and the bis-(trimethylsilyl) derivative of this compound gave a single peak on g.l.c. with a relative retention time of 4.54 (240°C), identical with the retention time predicted on the basis of the known retention time of the trimethylsilyl ether 5,6-trans-cholecalciferol and the increment to be expected for a 25-trimethylsilyloxy group.
Non-radioactive 25-hydroxy-5,6-trans-cholecalciferol was also prepared by the same procedure.
Results

Dihydrotachysterol
The concentration of radioactivity in the tissues of rachitic chicks and rats after an intracardial dose of is much lower than has been found with an equivalent dose of radioactive cholecalciferol. In general the tissues ofthe two species contained similar amounts of total radioactivity except for rat liver and kidney which contained significantly more radioactivity than chick liver and kidney (Table 1) . No pattern could be discerned in the difference in the amounts of tissue radioactivity found with these two doses.
Chromatography ofthe tissue lipid extracts showed Fraction no. 1.6 24.1 that more metabolites are formed from dihydrotachysterol3 than are observed after the administration of cholecalciferol. Fractionation of blood lipids from the chick and the rat on a column of silica gel with gradient elution showed essentially the same pattern in both animals, of seven major peaks of radioactivity (Fig. 3) .
No attempt was made to identify all the metabolites of dihydrotachysterol3 in blood and tissues with certainty, but it was established that in all the chromatographic systems used large proportions of the radioactivity co-chromatographed exactly with authentic standards. The resolution achieved with gradient elution from the silica-gel column allowed a more exact measurement ( Fig. 3 and Table 2 ) than was achieved with the t.l.c. system. Thus peaks III and IV co-chromatographed exactly with authentic dihydrotachysterol3 and 25-hydroxydihydrotachysterol3 respectively. Peak I is most probably the ester form of dihydrotachysterol3, since on saponification of this fraction and chromatography on silica gel the radioactivity was recovered in the dihydrotachysterol3 region. Peak VII corresponded to the position of the dihydroxymetabolites of vitamin D observed in tissues after administration of the vitamin to animals. The nature of the radioactivity in the other peaks was not investigated. For routine purposes the tissue lipids were analysed by the t.l.c. system in which the developing solvent was ethyl acetateheptane (1:1, v/v), and the radioactivity was proportioned according to the amounts found in the area of the authentic standards (Table 3 ). However, it should be emphasized that the radioactivity in the position ofthe monohydroxy compounds is primarily due to dihydrotachysterol and in the position of the dihydroxy compounds to the 25-hydroxy metabolite of this steroid.
The main radioactive component of the blood of rats that had received dihydrotachysterol3 18h previously was the25-hydroxymetabolite. Decreasing the dose of the steroid raised the proportion of this metabolite found in blood, with consequent decrease 1974 42 of the other metabolites (Table 2) . In tl ever, the major components were th metabolites found in peak VII, and the ficant increase in the proportion of tU the dose of the steroid was decreased. of radioactivity from these columns wa The proportion was measured of components found in the other tissues 4 given 0.5,ug of the radioactive stero The major component in the rat tissue, is 25-hydroxydihydrotachysterol3. Ir however, the pattern is more varied. muscle, dihydrotachysterol3 accounts fc of the radioactivity, whereas in the similar proportions are found of this s its more polar metabolites. The effect in Vol. 142 2 raising the dose of dihydrotachystero13 to 10,ug per animal was to increase the proportion of this steroid I still present after 24h.
The most polar fraction (peaks VI and VII) in Jo chick and rat tissues co-chromatographs with the dihydroxy metabolites of cholecalciferol on columns of silica gel and on t.l.c. These metabolites of cholecalciferol can be effectively separated on Sephadex LH-20 columns (Lawson et aL, 1971a; Suda et al., 1970) . The application of this procedure to the dihydroxy metabolites of dihydrotachysterol3 separated them into three fractions, none of which was in the same region as 1,25-dihydroxycholecalciferol. Table 3 with no indication ofa change extinction at in 3H/14C ratio in any fraction. A further group of 2,25-hydroxythree rachitic rats received 10,ug of the doublelabelled dihydrotachysterol2 and the lipid extracts were chromatographed. Fig. 4 shows the 3H and 14C he chick, howelution profile of the eluate from a column of e more polar Sephadex LH-20.
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oid (Table 3) .
In other experiments we have shown that the pattern s, as in blood, of metabolites in intestine, bone and blood was a the chick, unchanged in anephric rats.
In bone and The question arises therefore as to the nature of the )r themajority radioactivity in the intestinal nuclei which, from (Lawson et al., 1971b) . The lipids extracted from these two intracellular fractions and a portion of the total homogenate were chromatographed by t.l.c. The type and proportions of the metabolites found in cytosol and nuclear fraction did not differ either from each other or from that found in the total homogenate (Fig. 5) .
Biliary excretion ofdihydrotachysterol
The poor recoveries of radioactivity (about 50%) from the chromatographies of the lipid extracts of all the tissues, except blood, suggested the presence of a very polar metabolite of dihydrotachysterol. Lipid extracts of portions ofliver and intestine from rachitic rats dosed with 0.5tg of dihydrotachysterol contained 1.6 and 1.1 % of the dose respectively. The proportion ofthisradioactivity found in the unsaponifiable material of these tissues was 47.4 % for the liver and 22.9 % for the intestine. The radioactivity remaining in the saponification mixture in both cases became soluble in ether only after acidification of the mixture. This suggested that the radioactivity in this fraction was associated with a substance containing a carboxyl group. The material soluble in ether after acidification was chromatographed on a column of silica gel that had been activated at 120°C for 5 days. The column was developed with increasing proportions ofacetone in benzene. Such a system has been of value in the separation of bile acids (Eneroth & Sjovall, 1969) . The 8 % (v/v) acetone in benzene fraction contained 67% of the recovered radioactivity, with a further 26% of the radioactivity in the 30% acetone in benzene fraction. The total recovery of radioactivity in this system was 80.4 %. These results imply that the majority of the very polar radioactivity in tissues is associated with a substance containing one hydroxyl and one carboxyl group. Rachitic rats that had received 0.5,ug of radioactive dihydrotachysterol excreted about 17 % of the dose, of which about 10% was acidic in nature.
Metabolism of 5,6-trans-cholecalciferol In common with dihydrotachysterol, very little radioactivity from either labelled 5,6-trans-cholecalciferol or labelled 25-hydroxy-5,6-trans-cholecalciferol was recovered in the tissues of rachitic chicks (Table 4) . However, the chromatographic pattern was much simpler, with no evidence of a large number of metabolites, but instead the pattern more closely resembled that obtained with a dose of cholecalciferol. The major component in liver, intestine and bone was unchanged trans-cholecalciferol, whereas the 25-hydroxy metabolite was the main radioactive component in the blood (Table 5 ). All tissues contained a significant amount ofa fraction with chromatographic properties similar to those of the dihydroxy metabolites of cholecalciferol. When the rachitic chicks were dosed with 25-hydroxy-5,6-trans-cholecalciferol the main component was this more polar fraction. As expected if 5,6-transcholecalciferol is active in anephric rats, the high proportion of polar radioactivity in the intestine did not contain a 1-hydroxylated component. This was shown by the administration of 0.125,ug of 5,6-trans- ratio. In other experiments pure intestinal nuclei were prepared, from rachitic birds that had received 5jug of 5,6-trans-[1,2-3H]cholecalciferol. The lipids were extracted and chromatographed and found to be identical with the pattern found for the whole intestine.
Discussion
Convincing evidence now exists from this and other studies (Hallick & DeLuca, 1972; Holick et al., 1972) that dihydrotachysterol and 5,6-trans-cholecalciferol do not undergo hydroxylation at C-1 in vivo, despite the fact that the 25-hydroxy derivatives of both steroids will act as substrates for the 1-hydroxylase enzyme in incubations of kidney homogenates (D. R. Fraser, personal communication). Although we have found large quantities of polar metabolites of these analogues in the tissues examined of the rat and chick, no portion co-migrated with 1,25-dihydroxycholecalciferol in all chromatographic systems. Further, no metabolites of [4-'4C, 1-3H]-dihydrotachysterol2 or 5,6-trans-[4-14C,1,2-3H]-cholecalciferol were detected with a lowered 3H/14C ratio, nor was there any evidence that the metabolism of dihydrotachysterol in anephric rats differed from that in intact animals. These findings agree with those of Hallick, & DeLuca (1972) , who showed that 5,6-trans-cholecalciferol and dihydrotachysterol were as active in calcium absorption and bone mobilization in anephric rats as in sham-operated animals. The question arises therefore as to the metabolically active form of these analogues. Hallick & DeLuca (1972) did not find in rat bone any metabolite of dihydrotachysterol more polar than 25-hydroxydihydrotachysterol and concluded therefore that this metabolite was the active form in this tissue. They were Vol. 142 unable to decide whether the active form in the intestine was 25-hydroxydihydrotachysterol, or a more polar metabolite, or both. In the present study polar metabolites were found in all tissues and in some cases in very high amounts. After a low dose of cholecalciferol only one of the polar metabolites, 1,25-dihydroxycholecalciferol, is found in the intestinal nuclei. However, with both these analogues a number of metabolites were present in the nuclear fraction in the same proportion as found in the whole tissues.
In common with the other steroid hormones 1,25-dihydroxycholecalciferol is concentrated in its target tissues, but ofthe metabolites ofthese analogues only the concentrations of dihydrotachysterol and its 25-hydroxy derivative in the tissues were equal to or greater than their plasma concentrations. Consequently it is to be expected that the affinity of the tissue receptors for these steroids will be much less than for 1,25-dihydroxycholecalciferol and of the same order as the affinity of these analogues with the plasma transporting proteins. It is possible that the dominant factor in the structure of the steroids influencing the magnitude of the affinity, particularly for the target tissue receptors, is a hydroxyl group at approximately the same steric position as that at C-1 of cholecalciferol. Hence the finding that the complete pattern of tissue steroids is also present in the intestinal nuclei. The low potency ofthese steroids and their rapid metabolism is also explicable on the basis of their relative binding affinities for the proteins which either transport or partake in the metabolism of cholecalciferol and its metabolites. We have shown (Preece et al., 1972) that the association constants of 25-hydroxydihydrotachysterol3 and 25-hydroxy-5,6-trans-cholecalciferol for rat plasma proteins is significantly lower than that for 25-hydroxycholecalciferol. Thus the plasma pool of these analogues will be much smaller than that of 25-hydroxycholecalciferol from an equivalent 45 46 D. E. M. LAWSON AND P. A. BELL amount of the parent steroid. On the other hand 1,25-dihydroxycholecalciferol is rapidly metabolized (Lawson & Emtage, 1974) and the enzymes or protein cofactors involved may take up the analogues and be responsible for their rapid metabolism, thus accounting for the well established short biological half-life of the dihydrotachysterols.
